About Siga Technologies (OTCMKTS:SIGA)
SIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.
Industry, Sector and Symbol:
- Industry: Biotechnology
- Sub-Industry: Biotechnology
- Sector: Medical
- Symbol: OTCMKTS:SIGA
- Previous Symbol: NASDAQ:SIGA
- CUSIP: 82691710
- Web: www.siga.com
- Debt-to-Equity Ratio: -0.22%
- Current Ratio: 3.14%
- Quick Ratio: 2.91%
Sales & Book Value:
- Annual Sales: $14.99 million
- Price / Sales: 23.48
- Cash Flow: $0.50 per share
- Price / Cash: 8.88
- Book Value: ($3.65) per share
- Price / Book: -1.22
- Trailing EPS: ($0.53)
- Net Income: ($39,690,000.00)
- Net Margins: -201.85%
- Return on Assets: -23.22%
- Employees: 36
- Outstanding Shares: 78,910,000
Frequently Asked Questions for Siga Technologies (OTCMKTS:SIGA)
What is Siga Technologies' stock symbol?
Siga Technologies trades on the OTCMKTS under the ticker symbol "SIGA."
How were Siga Technologies' earnings last quarter?
Siga Technologies Inc. (OTCMKTS:SIGA) posted its quarterly earnings data on Thursday, May, 1st. The biotechnology company reported ($0.06) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.22 by $0.28. The biotechnology company earned $0.55 million during the quarter, compared to analyst estimates of $26.50 million. View Siga Technologies' Earnings History.
When will Siga Technologies make its next earnings announcement?
Who are some of Siga Technologies' key competitors?
Some companies that are related to Siga Technologies include Theratechnologies (TH), Mirati Therapeutics (MRTX), OrganiGram Holdings (OGI), VBI Vaccines (VBIV), Osiris Therapeutics (OSIR), XOMA Corporation (XOMA), Anavex Life Sciences Corp. (AVXL), Trillium Therapeutics (TRIL), Aevi Genomic Medicine (GNMX), ContraFect Corporation (CFRX), Concordia International Corp (CXR), Soligenix (SNGX), Senesco Technologies (SVON), Mateon Therapeutics (MATN), Windtree Therapeutics (WINT), Affymax (AFFY), TetraLogic Pharmaceuticals Corporation (TLOG) and Cubist Pharmaceuticals (CBST).
Who are Siga Technologies' key executives?
Siga Technologies' management team includes the folowing people:
- Eric A. Rose M.D., Executive Chairman of the Board (Age 66)
- Phillip Louis Gomez III, Chief Executive Officer, Director (Age 49)
- Daniel J. Luckshire, Chief Financial Officer, Executive Vice President, Secretary (Age 44)
- Dennis E. Hruby Ph.D., Chief Scientific Officer, Vice President (Age 63)
- James J. Antal CPA, Independent Director (Age 65)
- Michael Jonathan Bayer, Independent Director (Age 66)
- Thomas E. Constance, Independent Director (Age 81)
- Jeffrey B. Kindler, Independent Director (Age 61)
- Joseph W. Marshall III, Independent Director (Age 64)
How do I buy Siga Technologies stock?
Shares of Siga Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Siga Technologies' stock price today?
One share of Siga Technologies stock can currently be purchased for approximately $4.46.
How big of a company is Siga Technologies?
Siga Technologies has a market capitalization of $355.09 million and generates $14.99 million in revenue each year. The biotechnology company earns ($39,690,000.00) in net income (profit) each year or ($0.53) on an earnings per share basis. Siga Technologies employs 36 workers across the globe.
How can I contact Siga Technologies?
Siga Technologies' mailing address is 27 EAST 62ND STREET, NEW YORK NY, 10065. The biotechnology company can be reached via phone at 212-672-9100 or via email at [email protected]
MarketBeat Community Rating for Siga Technologies (OTCMKTS SIGA)MarketBeat's community ratings are surveys of what our community members think about Siga Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Siga Technologies (OTCMKTS:SIGA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Siga Technologies (OTCMKTS:SIGA)
Analysts' Ratings History for Siga Technologies (OTCMKTS:SIGA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for Siga Technologies (OTCMKTS:SIGA)
Earnings History by Quarter for Siga Technologies (OTCMKTS SIGA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/22/2017|| || || || || || || || |
|5/1/2014||Q1||$0.22||($0.06)||$26.50 million||$0.55 million||View||Listen|
|3/10/2014||Q413||($0.08)||$2.50 million||$0.90 million||View||N/A|
|3/6/2013||Q4 2012||($0.07)||($0.06)||$5.00 million||$2.50 million||View||N/A|
|11/5/2012||Q312||$0.11||($0.06)||$3.60 million||$2.30 million||View||N/A|
Earnings Estimates for Siga Technologies (OTCMKTS:SIGA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Siga Technologies (OTCMKTS:SIGA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Siga Technologies (OTCMKTS SIGA)
Insider Ownership Percentage: 4.71%
Institutional Ownership Percentage: 7.16%
Insider Trades by Quarter for Siga Technologies (OTCMKTS SIGA)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/7/2014||& Forbes Holdings I Macandrews||Director||Buy||199,727||$1.50||$299,590.50|| |
|9/26/2014||Bruce Slovin||Director||Sell||25,000||$1.35||$33,750.00|| |
|9/24/2014||& Forbes Holdings I Macandrews||Director||Buy||204,157||$1.34||$273,570.38|| |
|9/23/2014||& Forbes Holdings I Macandrews||Director||Buy||151,158||$1.33||$201,040.14|| |
|9/17/2013||Michael Bayer||Director||Buy||15,000||$3.58||$53,700.00|| |
|9/13/2013||Michael Bayer||Director||Sell||15,000||$3.55||$53,250.00|| |
|5/30/2013||Bruce Slovin||Director||Sell||15,000||$3.83||$57,450.00|| |
|5/24/2013||Joseph W Marshall III||Director||Buy||7,000||$3.59||$25,130.00|| |
Latest Headlines for Siga Technologies (OTCMKTS SIGA)
No headlines for this company have been tracked by MarketBeat.com
Siga Technologies (OTCMKTS SIGA) Chart for Monday, November, 20, 2017